Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Protozoan infections
MeSH D011528 - protozoan infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010272:
Parasitic diseases
0 Companies
0 Drugs
Success rate
D011528:
Protozoan infections
170 Companies
44 Drugs
$
Success rate
D000562:
Amebiasis
58 Companies
7 Drugs
$
Success rate
D001404:
Babesiosis
6 Companies
1 Drug
$
Success rate
D003048:
Coccidiosis
0 Companies
0 Drugs
Success rate
D004030:
Dientamoebiasis
0 Companies
0 Drugs
Success rate
D005873:
Giardiasis
56 Companies
7 Drugs
$
Success rate
D008288:
Malaria
43 Companies
17 Drugs
$
Success rate
D011529:
Animal protozoan infections
0 Companies
0 Drugs
Success rate
D013801:
Theileriasis
0 Companies
0 Drugs
Success rate
D014245:
Trichomonas infections
0 Companies
0 Drugs
Success rate
D016770:
Ciliophora infections
0 Companies
0 Drugs
Success rate
D020808:
Central nervous system protozoal infections
0 Companies
0 Drugs
Success rate
D056986:
Euglenozoa infections
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
33
%
2/6
Phase 2
0
%
0/2
Phase 3
96
%
26/27
Approved:
26
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Erythromycin lactobionate
,
Metronidazole
Allergan
Ciprofloxacin
,
Gatifloxacin
,
Levofloxacin
,
Metronidazole
,
Ofloxacin
,
Tetracycline
1
2
3
4
5
6
...
12
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use